Alzheimer Disease: Diffusion Tensor MRI ...

Dr. Linda Chu welcomes Dr. Robert McDonald (Mayo Clinic) and Dr. Paul Evans (GE HealthCare) for a discussion on the evolution of MR contrast agents, exploring how gadolinium has changed MRI diagnostics and what decades of clinical experience have taught the radiology community. T ... Show More

Dr. Reni Butler speaks with Dr. Bryan Haslam, Dr. Greg Sorensen, Dr. Matt McCabe, and Dr. Christoph Lee about their large real-world study evaluating an AI driven workflow for screening mammography across 109 U.S. facilities. Together, they explore how AI helped general radiologi ... Show More

Host Dr. Linda Chu sits down with Dr. Jie Nguyen, Dr. Todd Lawrence, and Dr. Kirk Davis to discuss an interdisciplinary consensus on standardized knee meniscus MRI reporting and the terminology that improves communication between radiologists and orthopedic surgeons. Together, th ... Show More

<p>In this interview, dementia expert Gil D. Rabinovici, MD, discusses monoclonal antibodies that target beta-amyloid–-including a recent phase 3 trial of donanemab published in JAMA-–and reviews considerations for their use in patients with Alzheimer disease.<br /> <br /> <stron ... Show More

Dr. Rae Bacharach discusses the Neurology Today article, "Individuals Can Now Request a Blood Test for Alzheimer disease - Why Some Dementia Experts Are Wary". Show references: https://journals.lww.com/neurotodayonline/fulltext/2023/10190/individuals_can_now_request_a_blood_test_ ... Show More

Dr. Greg Cooper talks with Dr. Joseph Therriault about the use of plasma biomarkers in diagnosing Alzheimer disease, emphasizing the importance of interpreting these biomarkers within the clinical context of the patient. Read the related article in Nature. Disclosures can be foun ... Show More

<p class="MsoNormal">This episode is a conversation with Drs. Clifford Jack and Kevin Duff about recent updates to the diagnosis and staging of Alzheimer's disease (AD). We discuss biological versus clinical/pathological approaches to diagnosing AD, analogies between AD and other ... Show More

<p>Dr. Trey Bateman talks with Dr. Amy Brodtmann about the complexities of diagnosing FTD and related disorders, emphasizing the need to understand frontal network impairments and the importance of behavioral assessments and psychiatric history in clinical practice.</p> <p>Read t ... Show More

There are 6 million Americans living with Alzheimer's Disease. This program explains the latest understanding of the anatomy and functions of the brain and how it relates to neurological diseases. Dr. Gil Rabinovici is at the forefront of novel diagnostic testing to detect Alzhei ... Show More

Dr. Jason Crowell talks with Dr. Christopher Gibbons to discuss his paper "Cutaneous Phosphorylated Alpha-Synuclein Deposition in Dementia with Lewy Bodies and Mild Cognitive Impairment."   Show reference:  https://index.mirasmart.com/AAN2024/SearchResults.php?Program_Number=PL4. ... Show More

This episode explores the current state of research on the multiple likely mechanisms of Alzheimer’s disease as well as promising treatments and diagnostics. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2309944. 

Dr. Kenneth Langa discusses his paper, "Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US". Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2797274?resultClick=1 This episode is brought to you by Mass General Brigham De ... Show More

In part 1 of a 3 part series, Cyrus A. Raji, MD, Ph.D., discusses his article, "The Value of Neuroimaging in Dementia Diagnosis" from the June Continuum Dementia issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/Neuro ... Show More